Search
for
Sort by
Research 121–150 of 338
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Alopecia Areata Possibly Secondary to COVID-19 Vaccine
- An Updated in the Management of Alopecia Areata
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Proceedings of the Ninth World Congress for Hair Research (2015)
- Female Pattern Hair Loss: An Overview with Focus on the Genetics
- Photobiomodulation for the management of hair loss
- Treatment options for alopecia areata
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Non-scarring patchy alopecia in patients with systemic lupus erythematosus differs from that of alopecia areata
- Alopecia areata
- Healing beyond the surface: A constitutional homeopathic approach to alopecia AREATA: A case study
- Clinical relevance of hair microscopy in alopecia
- Incipient Diabetes Mellitus and Nascent Thyroid Disease Presenting as Beard Alopecia Areata: Case Report and Treatment Review of Alopecia Areata of the Beard
- Hair loss and its management in children
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Modern Management Approaches for Alopecia Areata
- Focal Asymptomatic Hair Loss in an Adolescent: A Case Report
- Autoimmune associations of alopecia areata in pediatric population - A study in tertiary care centre
- Alopecia areata - Vitiligo overlap syndrome: An emerging clinical variant
- Lichen planopilaris associated with hair extensions in a patient with alopecia areata: A case report
- Expression of CD117 and platelet-derived growth factor receptor α in patients with alopecia areata
- A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
- A comprehensive investigation into the molecular mechanism responsible for selective androgen receptor (SARM) tissue-selectivity
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Probing androgen receptor co-factor selectivity profiles: a chemical tool to determine cross-talk between androgen receptor and β-catenin in vivo
- Identification of Anabolic Selective Androgen Receptor Modulators with Reduced Activities in Reproductive Tissues and Sebaceous Glands
- Clinical facts and curios
- Editorial for issue 3 of 2012, Journal of Evidence Based Medicine